2024-11-14 | Purchase | Assertio Holdings, Inc. ASRT | CEO | | $0.85 | $9,950 | -4.54% | |
2021-03-05 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $10.54 | $241,160 | -10.08% | |
2021-03-04 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $10.59 | $173,021 | -10.49% | |
2021-03-03 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $10.86 | $10,059 | -13.19% | |
2021-03-02 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $10.85 | $327,203 | -11.65% | |
2021-03-01 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $10.91 | $1.6M | -12.91% | |
2021-02-09 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $12.69 | $525,400 | -23.97% | |
2020-03-17 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $7.16 | $6,734 | +44.07% | |
2020-03-03 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $11.37 | $10,525 | -7.72% | |
2020-02-10 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $12.27 | $117,767 | -16.19% | |
2019-09-18 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $7.83 | $7,737 | +30.94% | |
2019-03-18 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $16.63 | $39,202 | -43.45% | |
2019-03-12 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $15.67 | $23,136 | -39.29% | |
2019-03-04 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $16.88 | $39,372 | -42.93% | |
2018-09-18 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $11.85 | $29,420 | -35.85% | |
2018-03-19 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $8.94 | $21,078 | +18.31% | |
2018-03-12 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $9.74 | $14,383 | +8.67% | |
2018-03-05 | Sale | Teva Pharmaceutical Industries Limited TEVA | EVP, North America Commercial | | $19.38 | $27,326 | +9.62% | |